221 related articles for article (PubMed ID: 35911954)
1. Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy.
Zhao Q; Hu W; Xu J; Zeng S; Xi X; Chen J; Wu X; Hu S; Zhong T
Front Mol Biosci; 2022; 9():919274. PubMed ID: 35911954
[TBL] [Abstract][Full Text] [Related]
2. The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer.
Sun X; Zhang Z; Wang Z; Xie R; Yi C; Liu H; Chi X; Li T; Liu H; Han Y; Pang X; Cui Y; Liu Z
Front Immunol; 2022; 13():1033967. PubMed ID: 36479101
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analyses of senescence-related genes in extracellular matrix characterization in cancer.
Yan B; Liao P; Shi L; Lei P
Discov Oncol; 2023 Nov; 14(1):208. PubMed ID: 37985530
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive pan-cancer analysis identifies cellular senescence as a new therapeutic target for cancer: multi-omics analysis and single-cell sequencing validation.
Zhang Q; Tang Y; Hu G; Yuan Z; Zhang S; Sun Y; Yin D; Dong C; Zhao J; Wu G; Huang X; Yang J; Tang Y
Am J Cancer Res; 2022; 12(9):4103-4119. PubMed ID: 36225642
[TBL] [Abstract][Full Text] [Related]
5. The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker.
Tu Z; Wang X; Cai H; Sheng Y; Wu L; Huang K; Zhu X
Aging (Albany NY); 2023 Mar; 15(6):2136-2157. PubMed ID: 36961395
[TBL] [Abstract][Full Text] [Related]
6. Leptin Receptor Overlapping Transcript (LEPROT) Is Associated with the Tumor Microenvironment and a Prognostic Predictor in Pan-Cancer.
Li B; He Y; Li P; Chen X
Front Genet; 2021; 12():749435. PubMed ID: 34804118
[TBL] [Abstract][Full Text] [Related]
7. The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response.
Wu G; He M; Yin X; Wang W; Zhou J; Ren K; Chen X; Xue Q
Front Immunol; 2022; 13():837665. PubMed ID: 35493463
[TBL] [Abstract][Full Text] [Related]
8. Integration analysis of senescence-related genes to predict prognosis and immunotherapy response in soft-tissue sarcoma: evidence based on machine learning and experiments.
Qi L; Chen F; Wang L; Yang Z; Zhang W; Li Z
Front Pharmacol; 2023; 14():1229233. PubMed ID: 37497116
[No Abstract] [Full Text] [Related]
9. A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence.
Wu Z; Uhl B; Gires O; Reichel CA
J Biomed Sci; 2023 Mar; 30(1):21. PubMed ID: 36978029
[TBL] [Abstract][Full Text] [Related]
10. Identification of Senescence-Related Subtypes, the Development of a Prognosis Model, and Characterization of Immune Infiltration and Gut Microbiota in Colorectal Cancer.
Dai JJ; Fu YY; Zhong XQ; Cen W; Ye MF; Chen XH; Pan YF; Ye LC
Front Med (Lausanne); 2022; 9():916565. PubMed ID: 35721059
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive assessment of cellular senescence in the tumor microenvironment.
Wang X; Ma L; Pei X; Wang H; Tang X; Pei JF; Ding YN; Qu S; Wei ZY; Wang HY; Wang X; Wei GH; Liu DP; Chen HZ
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35419596
[TBL] [Abstract][Full Text] [Related]
12.
Wu G; Chen M; Ren H; Sha X; He M; Ren K; Qi J; Lin F
Front Cell Dev Biol; 2022; 10():930933. PubMed ID: 35874816
[No Abstract] [Full Text] [Related]
13. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
14. Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers.
Tang K; Zhang J; Cao H; Xiao G; Wang Z; Zhang X; Zhang N; Wu W; Zhang H; Wang Q; Xu H; Cheng Q
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428755
[TBL] [Abstract][Full Text] [Related]
15. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
16. Pan-Cancer Analysis of the Oncogenic and Immunological Role of
Ding J; Meng Y; Han Z; Luo X; Guo X; Li Y; Liu S; Zhuang K
Front Oncol; 2022; 12():811567. PubMed ID: 35651805
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma.
He Y; Li J; Shen L; Zhou H; Fei W; Zhang G; Li Z; Wang F; Wen Y
Aging (Albany NY); 2022 Jan; 14(2):1033-1047. PubMed ID: 35093934
[TBL] [Abstract][Full Text] [Related]
18. The Pan-Cancer Crosstalk Between the
Xie R; Yuan M; Jiang Y
Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
[No Abstract] [Full Text] [Related]
19. Multi-omics landscape analysis reveals the pan-cancer association of arginine biosynthesis genes with tumor immune evasion and therapy resistance.
Tan Z; Li H; Huang Y; Fu S; Wang H; Wang J
Heliyon; 2024 Mar; 10(5):e26804. PubMed ID: 38468956
[TBL] [Abstract][Full Text] [Related]
20. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
Cheng X; Cao Y; Wang X; Cheng L; Liu Y; Lei J; Peng W; Shi D
J Immunol Res; 2022; 2022():5254911. PubMed ID: 35028320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
